Library
Learn more about psilocybin, psychedelic-assisted therapy, sample journeys for cancer patients, and more.
Introduction to psilocybin
Whether you are well-versed in psychedelic medicine, or you just watched your first documentary (How To Change Your Mind on Netflix is fantastic!), science has been advancing knowledge about psilocybin and psychedelics for decades.
Introduction to psychedelic-assisted therapy
Whatever prior knowledge or experience you have with psilocybin or other psychedelics, at Sachi we are focused on their legal and approved use as part of psychedelic-assisted therapy.
The psychedelic-assisted therapy experience: What to expect
Are you interested in learning about the actual experience of PAT? For those who have ever tried them before, you understand when we say results may vary.
How do I get access to psychedelic-assisted therapy?
We created Sachi to educate, and also to increase access to psychedelic therapies for cancer patients, survivors, and supporters. The easiest path to receive PAT in a controlled, safe setting is to enroll in a clinical trial, or to find a legal clinic in Oregon or Colorado.
Clinical trials for psilocybin and other research in cancer
Learn about the clinical trials and research from around the world exploring the power of psilocybin for cancer patients.
Why are we focused on the mental and emotional battle?
1 in 4 cancer patients suffer from depression. Your mental health is equally as important as your physical health.
How does psilocybin affect us?
There are many reports and online sources available about psilocybin and how it feels to “trip” on psychedelics. No matter what you read, remember: everybody’s experience with psychedelics is different. While everyone will have their own journey with psilocybin, there are several common themes that are often repeated.
The history of psilocybin research
Psychedelics have been consumed and used by human beings since before recorded history. Whether in natural form (psilocybin, mescalin, ayahuasca, etc.), or synthetic (MDMA, LSD, etc.), scientists have long wondered about their potential benefits for the human mind. While research papers have discussed their benefits since the discovery of MDMA in the 1910s and the discovery of LSD in 1938, we focus on the research that emerged after the “dark period” that started with the UN Convention on Psychotropic Substances of 1971.
State and local-level rules for psychedelic guides and facilitators
Oregon and Colorado are the first two states to decriminalize psilocybin and other psychedelics in the United States. However, their regulations and license requirements vary dramatically.